ArticleInfectious diseases of poverty2016
Access to and affordability of healthcare for TB patients in China: issues and challenges.
Article in Infectious diseases of poverty, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Experiences of Strategic Purchasing of Healthcare in Nine Middle-Income Countries: A Systematic Qualitative Review.International journal of health policy and management · 2023Pooled it
- Economic burden of MDR/RR-TB and implementation of a treatment subsidy policy in Lishui City, China: a retrospective study following strobe guidelines.BMC health services research · 2026Article
- Financial Feasibility of BPaL(M) Under Pretomanid Price Scenarios - China, 2023-2024.China CDC weekly · 2026Article
- Age-specific clinical profiles and economic burden of pediatric tuberculosis: a 5-year retrospective study in central China.BMC infectious diseases · 2026Article
- Characteristics and economic burden of hospitalized tuberculosis patients in Guangdong Province, China, from 2017 to 2023: a population-based study.BMC infectious diseases · 2025Article
- Socioeconomic determinants of affordability of medication: a panel data econometric analysis in Iran.BMC health services research · 2025Article
- Differences Between the Local and Migrant Populations in Healthcare Service Use and Direct Cost of Tuberculosis Treatment - Shanghai Municipality, China, 2020-2021.China CDC weekly · 2025Article
- Spatiotemporal analysis of pulmonary tuberculosis in the central region of the Zhejiang Province, China (2016-2024).Frontiers in public health · 2025Article
- Health insurance's contribution to reducing the financial burden of tuberculosis in Guizhou Province, China.Epidemiology and infection · 2024Article
- Impacts of Medical Security Level on Treatment Outcomes of Drug-Resistant Tuberculosis: Evidence from Wuhan City, China.Patient preference and adherence · 2022Article
- Impacts of a comprehensive tuberculosis control model on the quality of clinical services and the financial burden of treatment for patients with drug-resistant tuberculosis in China: a mixed-methods evaluation.Infectious diseases of poverty · 2021Article
- Article
- Scale-up of a comprehensive model to improve tuberculosis control in China: lessons learned and the way forward.Infectious diseases of poverty · 2021Article
- Process evaluation of E-learning in continuing medical education: evidence from the China-Gates Foundation Tuberculosis Control Program.Infectious diseases of poverty · 2021Article
- Impact of multiple policy interventions on the screening and diagnosis of drug-resistant tuberculosis patients: a cascade analysis on six prefectures in China.Infectious diseases of poverty · 2021Article
- Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study.Infectious diseases of poverty · 2020Article
- Analysis of the economic burden of diagnosis and treatment on patients with tuberculosis in Bao'an district of Shenzhen City, China.PloS one · 2020Article
- Under-reporting of TB cases and associated factors: a case study in China.BMC public health · 2019Article
- Transforming tuberculosis (TB) service delivery model in China: issues and challenges for health workforce.Human resources for health · 2019Article
- Utilization and expenses of outpatient services among tuberculosis patients in three Chinese counties: an observational comparison study.Infectious diseases of poverty · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper introduces the background, aim and objectives of the project entitled "China-the Gates Foundation Collaboration on TB Control in China" that has been underway for many years. It also summarizes the key findings of the nine papers included in this special issue, which used data from the baseline survey of Phase II of the project. Data were collected from the survey of TB and MDR-TB patients, from designated hospitals, health insurance agencies and the routine health information systems, as well as key informant interviews and focus group discussions with relevant key stakeholders. Key issues discussed in this series of papers include the uses of TB services and anti-TB medicines and their determining factors related to socio-economic and health systems development; expenditures on TB care and the financial burden incurred on TB patients; and the impact of health insurance schemes implemented in China on financial protection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.